Tokushima, Japan

Takakuni Matsuda

This inventor holds 26 USPTO granted patents and 25 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Injectable Formulations. Top assignees: Otsuka Pharmaceutical Company, Limited, I. Otsuka Pharmaceutical Co., Ltd.. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takakuni Matsuda. Retrieved from https://idiyas.com/inventor/takakuni-matsuda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 57.7

 

 

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 175(Granted Patents)


Location History:

  • Tokushima, JP (2003 - 2017)
  • Tokushima-ken, JP (2015 - 2017)
  • Osaka, JP (2014 - 2024)

Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Injectable Preparation
Controlled Release
Pharmaceutical Composition
Aripiprazole
Water-Soluble Compounds
Benzazepine Derivatives
Hydrogel Suspension
Ophthalmic Suspension
Vasopressin Antagonists
Medical Packaging
Sterile Formulation
Active Substance Absorbency
26 patents (USPTO):Explore Patents

Title: Takakuni Matsuda: Pioneer in Injectable Preparations

Introduction

Takakuni Matsuda, an accomplished inventor based in Tokushima, Japan, holds an impressive portfolio of 26 patents. His innovative work primarily focuses on the development of injectable preparations that enhance the stability and usability of poorly soluble drugs.

Latest Patents

Matsuda's latest patents feature a significant advancement in injectable preparation technology. One of his key inventions aims to provide a storage-stable injectable preparation that comprises a poorly soluble drug as its active ingredient along with a suitable dispersion medium. Moreover, he has introduced a novel compact, lightweight prefilled syringe design that utilizes this injectable preparation. This remarkable invention ensures that the composition of the injectable preparation achieves a viscosity of 40 pascal-seconds or more in specific shear rate ranges while maintaining a viscosity of 0.2 pascal-seconds or less in higher shear rate ranges, enhancing the overall efficiency of drug delivery.

Career Highlights

Throughout his career, Takakuni Matsuda has made significant contributions to the pharmaceutical industry. He has been associated with renowned companies such as Otsuka Pharmaceutical Company Limited and I. Otsuka Pharmaceutical Co., Ltd. His work has not only advanced the field of injectable preparations but also set a new standard for stability and ease of use.

Collaborations

Matsuda has collaborated with notable professionals in the industry, including Yoshito Masuda and Yuso Tomohira. These collaborations have further propelled his innovative projects, resulting in the successful implementation of new technologies in drug formulation.

Conclusion

Takakuni Matsuda's unwavering commitment to innovation in the pharmaceutical field has positioned him as a leading inventor, particularly in the development of injectable preparations. His extensive patent portfolio reflects his dedication to improving drug delivery systems, benefitting countless patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…